Join to access to all OVN content. Join for Free

Results for 'sponsorship'

Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility

clinical trials, industry, oncology, pediatric, sponsorship

The sponsorship mix of trials relevant to young people with cancer has not been well-documented, which may impact policies and regulations in pediatric cancer drug development. An analysis of interventional trials in the U.S. from 2007 to 2018 was conducted using the ClinicalTrials.gov registry, …

Apr 29th • 8 mins read

Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V. Neel, David S. Shulman, Clement Ma, Florence Bourgeois, Steven G. DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility

clinical trials, sponsor, pediatric clinical trials, sponsorship

The analysis focuses on the sponsorship of interventional oncology trials for patients under 18 in the U.S. There are fewer industry-sponsored trials for pediatric oncology compared to adult trials and other pediatric disciplines. Industry-sponsored trials tend to be phase III, enroll more patie…

Apr 29th • 6 mins read

Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival: A Pooled Analysis
OVN Avatar Alfredo Addeo, MD; Glen J. Weiss, MD, MBA; Bishal Gyawali, MD, PhD
Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival: A Pooled Analysis

pooled analysis, FDA, negative phase 3 trials, phase 3 trial, RCT, PRISMA, RCT's

In this study of trials published in 2016 through 2018, approximately 40% of negative phase 3 RCTs in oncology were conducted without supporting phase 2 trials, and such phase 3 trials were sponsored by both academia and industry. On the basis of our results, proactive steps from regulators and ethi…

May 10th • 8 mins read

MSL Hiring and Recruitment: 5 Ways to Support Diversity and Inclusion
Partner Avatar Tom Caravela
MSL Hiring and Recruitment: 5 Ways to Support Diversity and Inclusion

Medical Science Liaison hiring, diversity and inclusion recruitment, diverse interview panel, employee referral program, diversity sourcing strategies

While the COVID-19 pandemic wreaked havoc on many industries, Medical Science Liaison hiring was steady throughout 2020 and continues to remain strong in 2021. The one change in hiring that has become evident is the increase in recruitment practices that support diversity and inclusion. While we may…

May 19th • 2 mins read

Professional Medical Writer Assistance in Oncology Clinical Trials
OVN Avatar Ramez Kouzy , Joseph Abi Jaoude , Walker Mainwaring , Timothy A. Lin , Austin B. Miller , Amit Jethanandani , Andres F. Espinoza , Vivek Verma , Clifton D. Fuller , Bruce D. Minsky , Claus Rödel , Cullen M. Taniguchi , Ethan B. Ludmir
Professional Medical Writer Assistance in Oncology Clinical Trials

PMW usage, phase III oncology trials, professional medical writer assistance

The use of professional medical writers (PMWs) in oncologic phase III randomized controlled trials (RCTs) has been historically low, but recent data on their usage is limited. This study aimed to quantify the usage of PMWs in cancer-specific phase III RCTs by analyzing trial manuscripts on Clinic…

Sep 17th • 7 mins read

Related Topics

Loading...